Postrenal transplant infection: What is the effect of specific immunosuppressant agents?

    loading  Checking for direct PDF access through Ovid

Abstract

Background:

Immunosuppression is a known risk for post-transplant infections. Little data exist on the risk contributions of specific agents for various infections.

Methods:

A triply robust propensity score–adjusted analysis was performed in a renal transplant cohort between February 2006 and January 2014. The study was performed to identify the incidence and the risk factors for developing a post-transplant infection. After initial bivariate analysis, a triply robust propensity score–adjusted multivariate logistic regression was performed.

Results:

The mean age of the 717 renal transplant recipients was 50.0 ± 13.3 years, with the majority being male (61.6%) and 349 (48.7%) experiencing at least 1 post-transplant infection. Neither race, graft type, nor insurance status was associated with an increased incidence or risk of infection. In a fully adjusted regression model, the immunosuppressants mycophenolic acid mofetil (OR 0.38, 95% CI 0.21–0.71; P < .001) and alemtuzumab (OR 0.40, 95% CI 0.19–0.85; P=.020) were protective.

Conclusion:

Alemtuzumab and mycophenolic acid mofetil as immunosuppressant agents in a multiagent protocol appear to decrease the incidence of infection. Cytomegalovirus antigenemia was the greatest risk for infection and mycophenolic acid mofetil possessed the greatest protective effect on viral infections.

Related Topics

    loading  Loading Related Articles